Načítá se...
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity
[Image: see text] We report the development and characterization of compound 22 (MK-5046), a potent, selective small molecule agonist of BRS-3 (bombesin receptor subtype-3). In pharmacological testing using diet-induced obese mice, compound 22 caused mechanism-based, dose-dependent reductions in foo...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical Society
2010
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4018145/ https://ncbi.nlm.nih.gov/pubmed/24900253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml100196d |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|